At SiNON Nano Sciences, we are advancing therapeutic innovation with our patented carbon nanoparticle technology. This platform transforms drug delivery by boosting bioavailability, extending half-life, and lowering toxicity through targeted delivery. Our nanoparticles effectively cross the Blood-Brain Barrier, tackling critical challenges that have restricted the success of certain therapies in clinical trials. Additionally, our technology can extend the lifecycle of near-expiration drugs, revitalizing them with optimized formulations and broader therapeutic applications.

Our mission is to leverage this unique technology for both large biologics and small molecules, delivering meaningful advancements in healthcare through science-driven solutions.

Our founders and scientific advisors bring extensive expertise from leading academic institutions and the biotech industry, uniting deep knowledge with innovation to address today’s complex medical challenges.